Analysis of Hematological Examination Results in Pulmonary Tuberculosis (TB) Patients Undergoing Intensive Phase Anti-Tuberculosis Drug Therapy
The intensive phase of anti-tuberculosis (TB) drug therapy consists of a combination of antibiotics, including Isoniazid (INH), Rifampicin (RIF), Pyrazinamide (PZA), and Ethambutol (EMB). The primary goal of this therapy is to inhibit the growth and spread of Mycobacterium tuberculosis, preventin...
Saved in:
| Main Author: | Asbar Tanjung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Nahdlatul Ulama Surabaya
2024-08-01
|
| Series: | Jurnal Ilmiah Kesehatan |
| Subjects: | |
| Online Access: | https://journal2.unusa.ac.id/index.php/JHS/article/view/5792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hematological Indices of Sickle Cell Anaemia Patients with Pulmonary Tuberculosis in Northern Nigeria.
by: Sagir G. Ahmed, et al.
Published: (2010-06-01) -
Evaluating hematological and inflammatory biomarkers in tuberculosis management
by: Sanatkumar Bharamu Nyamagoud, et al.
Published: (2025-07-01) -
Haematological markers as predictive tools for tuberculosis in PLHIV: a retrospective cohort study in Gujarat, India
by: Yogesh M, et al.
Published: (2025-02-01) -
CORRECTION OF SOME SIDE EFFECTS TO ANTI-TUBERCULOSIS THERAPY IN MODERN CONDITIONS
by: Yu.V. Prosvetov, et al.
Published: (2022-06-01) -
Frequency of Anemia in Patients with Newly Diagnosed Pulmonary Tuberculosis Presenting at Dr Ruth KM Pfau Civil Hospital Karachi
by: Sana Muhammad Hussain, et al.
Published: (2024-03-01)